CHED - Congenital Hereditary Endothelial Dystrophy: New Paradigm Shift in Therapy Using Topical Eye Drops

NCT04843839 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Congenital Hereditary Endothelial Dystrophy of Cornea

Interventions

DRUG: Nepafenac 0.1% Oph Susp
DRUG: Refresh Tears 0.5% Lubricant Eye Drops

Sponsor

L.V. Prasad Eye Institute

Collaborators

[object Object]